Sanders Tri-Institutional Therapeutics Discovery Institute, Inc.

Biotechnology ResearchNew York, United States2-10 Employees

Sanders Tri-Institutional Therapeutics Discovery Institute is a nonprofit research partnership established to translate basic-science discoveries into therapeutics. It emphasizes early-stage drug discovery, offering expertise in medicinal chemistry and compound screening, and conducts proof-of-concept studies to show that drug candidates can meaningfully alter disease trajectories. As an independent organization with its own board of directors and scientific advisory committee, it coordinates activities across three leading academic centers to share core facilities and foster industry collaborations. Based in New York City, the institute also supports translational research and provides training opportunities for students and post-doctoral fellows, further engaging faculty in drug discovery. It seeks to create intellectual property that can be developed through partnerships with pharmaceutical and biotech companies in an open field of collaboration. In January 2025, the institute announced a collaboration with Quantum Computing Inc. to support research using Dirac-3 systems.

Sign up for free to view info

Email Format Employee directory